{"schema_version":"secwatch.filing_event.v1","accession":"0001659166-24-000146","form_type":"8-K","ticker":"FTV","cik":"0001659166","company_name":"Fortive Corp","filed_at":"2024-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.005275+00:00","generated_at":"2026-05-31T17:01:17.433211+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Fortive Q2 adj EPS $0.93 at high-end; narrows FY2024 outlook to $3.80-$3.86","bullets":["Q2 revenue $1.55B (+2% YoY), core flat; GAAP EPS $0.55, adj EPS $0.93 (high-end guidance).","Adjusted operating margin 27% (+90 bps YoY); operating cash flow $309M, free cash flow $280M.","FY2024 outlook: adj EPS $3.80-$3.86 (+11-13% YoY), GAAP EPS $2.68-$2.74 (+10-13%), revenue ~$6.25-$6.30B.","Q3 guidance: revenue ~$1.55B, GAAP EPS $0.63-$0.66, adj EPS $0.92-$0.95.","Strength in Advanced Healthcare & Intelligent Operating Solutions; delayed recovery in Precision Technologies."],"urls":{"canonical":"https://secwatch.observer/filing/0001659166-24-000146","json":"https://secwatch.observer/filing/0001659166-24-000146.json","markdown":"https://secwatch.observer/filing/0001659166-24-000146.md","text":"https://secwatch.observer/filing/0001659166-24-000146.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659166/000165916624000146/0001659166-24-000146-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659166/000165916624000146/ftv-20240724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T17:01:17.433211+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}